Relative progestational and androgenic activity of four progestins used for male hormonal contraception assessed in vitro in relation to their ability to suppress LH secretion in the castrate male rat
- 26 October 2010
- journal article
- research article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 328 (1-2), 16-21
- https://doi.org/10.1016/j.mce.2010.06.010
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Determinants of the Rate and Extent of Spermatogenic Suppression during Hormonal Male Contraception: An Integrated AnalysisJournal of Clinical Endocrinology & Metabolism, 2008
- A new highly specific and robust yeast androgen bioassay for the detection of agonists and antagonistsAnalytical and Bioanalytical Chemistry, 2007
- Dimethandrolone Undecanoate: A New Potent Orally Active Androgen with Progestational ActivityEndocrinology, 2006
- Chemistry and Structural Biology of Androgen ReceptorChemical Reviews, 2005
- Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cellsMolecular and Cellular Endocrinology, 2004
- Conception and pharmacodynamic profile of drospirenoneSteroids, 2003
- The Male Contraceptive Regimen of Testosterone and Levonorgestrel Significantly Increases Lean Mass in Healthy Young Men in 4 Weeks, but Attenuates a Decrease in Fat Mass Induced by Testosterone AloneJournal of Clinical Endocrinology & Metabolism, 2003
- CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914Molecular and Cellular Endocrinology, 2001
- Nestorone®: a progestin with a unique pharmacological profileSteroids, 2000
- Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistanceCell, 1982